No office rate
Use 37211 for initial-day thrombolytic infusion in an artery. Use 37212 when the treated vascular system is venous.
On this page
CMS RVU26D · Effective 2026-10-01
37212 Venous thrombolysis Medicare reimbursement rates in Michigan
Reports catheter-directed thrombolytic infusion in the venous system on the initial treatment day, such as treatment of an extensive acute venous thrombosis. Compare 37212 office and facility rates across CMS payment localities in Michigan.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 37212 in Michigan?
Michigan has 2 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 2 payment areas shown below, using the same CMS release.
Office / nonfacility
No supported rate
Facility setting
$296.99–$321.19
2 of 2 localities have a supported rate.
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Endovascular therapy
About 37212: Initial venous thrombolysis treatment
Reports catheter-directed thrombolytic infusion in the venous system on the initial treatment day, such as treatment of an extensive acute venous thrombosis.
This code represents the initial treatment day for delivering a thrombolytic drug into a vein through a catheter to dissolve a clot. A typical situation is catheter-directed treatment of extensive acute iliofemoral deep vein thrombosis. Interventional radiologists, vascular surgeons, and other physicians who perform endovascular procedures may provide the service, generally in a hospital or other facility. The code includes radiological supervision and interpretation associated with the thrombolytic treatment.
Report 37212 for the initial treatment day; continued treatment on a later day and stopping therapy with catheter removal are represented by separate codes in this family. Documentation should identify the venous target, the thrombus and clinical indication, the infusion performed, and that this is the initial treatment day. CMS assigns a 0-day global period, so same-day preoperative and postoperative care is included. When multiple procedures occur in the same session, the highest-valued procedure is paid in full and other procedures are subject to the standard 50% reduction. Modifier 50 applies to bilateral reporting, paid at 150%. Assistant-at-surgery payment requires documented medical necessity; co-surgeons and team surgery are not permitted.
CMS billing rules for 37212
- Global period
- Minor procedure with a 0-day global period: same-day preoperative and postoperative care is included.
- Multiple procedures
- Standard multiple procedure reduction: the highest-valued procedure is paid in full and others at 50% when performed in the same session.
- Bilateral procedures
- Bilateral procedure with modifier 50 is paid at 150%.
- Assistant at surgery
- Assistant at surgery is paid only with documentation of medical necessity.
- Co-surgeons
- Co-surgeons not permitted.
- Team surgery
- Team surgery not permitted.
Where the value comes from
- Work RVU6.64 · 75%
- Practice expense (office) RVU0.97 · 11%
- Malpractice RVU1.21 · 14%
765
Medicare services in 2024 · #3195 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
37212 compared with similar codes
Office rates for Michigan, from the same CMS release.
No office rate
37213 represents a subsequent treatment day, not the initial day represented by 37212.
No office rate
37214 applies when thrombolytic therapy is stopped and the catheter is removed; 37212 reports the initial treatment day.
Compare 37212 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
2 of 2 payment localities
Detroit →
Office / nonfacility
Unavailable
Facility
$321.19
Rest Of Michigan →
Office / nonfacility
Unavailable
Facility
$296.99
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
37212 billing questions
How does 37212 differ from 37211?
37212 is for thrombolytic infusion in the venous system; 37211 is for infusion in the arterial system. Select the code that matches the treated vascular system.
Can 37212 be reported again on a later treatment day?
No. Use 37212 for the initial treatment day; continued thrombolytic treatment on a subsequent day is represented by 37213.
Which code applies when thrombolytic treatment is stopped and the catheter is removed?
Use 37214 for cessation of thrombolytic therapy with catheter removal, rather than reporting another initial-day service.
Is radiological supervision and interpretation included?
Yes. The code includes radiological supervision and interpretation associated with the venous thrombolytic treatment.
What documentation supports reporting 37212?
Document the venous target, the clot and clinical indication, the thrombolytic infusion performed, and that the service was on the initial treatment day.
How does the bilateral payment rule affect 37212?
CMS pays bilateral reporting with modifier 50 at 150%. The code also follows the standard multiple-procedure reduction when other procedures are performed in the same session.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
4,58937200,,Transcatheter biopsy,A,,4.44,0.62,NA,0.62,,0.48,5.54,5.54,0,000,0.00,0.00,0.00,2,0,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
4,5903720F,,Cognit impairment assessed,M,,0.00,0.00,,0.00,,0.00,0.00,0.00,9,XXX,0.00,0.00,0.00,9,9,9,9,9,9,,33.4009,09,0,99,0.00,0.00,0.00
4,59137211,,Thrombolytic art therapy,A,,7.56,1.07,NA,1.07,,1.50,10.13,10.13,0,000,0.00,0.00,0.00,2,1,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
4,59237212,,Thrombolytic venous therapy,A,,6.64,0.97,NA,0.97,,1.21,8.82,8.82,0,000,0.00,0.00,0.00,2,1,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
4,59337213,,Thromblytic art/ven therapy,A,,4.63,0.58,NA,0.58,,0.85,6.06,6.06,0,000,0.00,0.00,0.00,2,0,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
4,59437214,,Cessj therapy cath removal,A,,2.43,0.31,NA,0.31,,0.47,3.21,3.21,0,000,0.00,0.00,0.00,2,0,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
4,59537215,,Transcath stent cca w/eps,R,,17.31,4.70,NA,4.70,,4.62,26.63,26.63,0,090,0.09,0.84,0.07,2,1,0,1,0,9,,33.4009,09,0,99,0.00,0.00,0.00